Stem cells for neurodegenerative disorders: Where can we go from here?

BioDrugs

Volumn 16, Issue 6, 2002, Pages 389-401

  Le Belle, Janel E ^a   Svendsen, Clive N ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DIFFERENTIATION; CELL POPULATION; CELL SURVIVAL; DEGENERATIVE DISEASE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; METABOLIC REGULATION; NERVE DEGENERATION; NERVE TRANSPLANTATION; NERVOUS SYSTEM INJURY; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STEM CELL; SURVIVAL RATE; TISSUE TRANSPLANTATION;

BRAIN; CELL SURVIVAL; CLINICAL TRIALS; FETAL TISSUE TRANSPLANTATION; HUMANS; NEURODEGENERATIVE DISEASES; PHENOTYPE; STEM CELL TRANSPLANTATION;

EID: 0036909332     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-200216060-00001     Document Type: Review

References (186)

1. Spencer DD, Robbins RJ, Naftolin F, et al. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 1992; 327 (22): 1589-90
2. Lindvall O, Sawle G, Widner H, et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 1994; 35: 172-80
3. Wenning GK, Odin P, Morrish P, et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 1997; 42: 95-107
4. Hagell P, Schrag A, Piccini P, et al. Sequential bilateral transplantation in Parkinson's disease: Effects of the second graft. Brain 1999; 122: 1121-32
5. Kordower JH, Freeman TB, Chen EY, et al. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov Disord 1998; 13: 383-93
6. Brundin P, Pogarell O, Hagell P, et al. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 2000; 123: 1380-90
7. Bjorklund A, Lindvall O. Cell replacement therapies for central nervous system disorders. Nat Neurosci 2000; 3 (6): 537-44
8. Freeman TB, Willing A, Zigova T, et al. Neural transplantation in Parkinson's disease. Adv Neurol 2001; 86: 435-45
9. Dunnett SB, Bjorklund A, Lindvall O. Cell therapy in Parkinson's disease: Stop or go? Nat Neurosci Rev 2001; 2: 365-9
10. Olanow CW, Kordower JH, Freeman TB. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 1996; 19: 102-9
11. Lindvall O. Cerebral implantation in movement disorders: State of the art. Mov Disord 1999; 14: 201-5
12. Lindvall O. Engineering neurons for Parkinson's disease. Nat Biotechnol 1999 Jul; 17 (7): 635-6
13. Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001; 344: 710-9
14. Herman JP, Abrous ND. Dopaminergic neural grafts after fifteen years: Results and perspectives. Prog Neurobiol 1994; 44: 1-35
15. Duan WM, Widner H, Brundin P. Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats. Exp Brain Res 1995; 104: 227-42
16. Barker RA, Dunnett SD, Faissner A, et al. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp Neurol 1996; 141: 79-93
17. Zawada WM, Zastrow DJ, Clarkson ED, et al. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res 1998; 786: 96-103
18. Emgard M, Karlsson J, Hansson O, et al. Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts. Exp Neurol 1999; 160: 279-88
19. Schierle GS, Hansson O, Leist M, et al. Caspase inhibition reduces apopotosis and increases survival of nigral transplants. Nat Med 1999; 5: 97-100
20. Shetty AK, Gopinath G, Tandon PN. Fetal nigral transplants in the lateral ventricle of adult rats: A long-term morphological study. Dev Neurosci 1991; 13 (1): 1-10
21. Lindvall O, Rehncrona S, Brundin P, et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease: A detailed account of methodology and a 6-month follow-up. Arch Neurol 1989 Jun; 46 (6): 615-31
22. Freed CR, Breeze RE, Rosenberg NL, et al. Transplantation of human fetal dopamine cells for Parkinson's disease: Results at 1 year. Arch Neurol 1990 May; 47 (5): 505-12
23. Lindvall O, Brundin P, Widner H, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 1990 Feb 2; 247 (4942): 574-7
24. Madrazo I, Franco-Bourland R, Ostrosky-Solis F, et al. Fetal homotransplants (ventral mesencephalon and adrenal tissue) to the striatum of parkinsonian subjects. Arch Neurol 1990 Dec; 47 (12): 1281-5
25. Henderson BT, Clough CG, Hughes RC, et al. Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease. Arch Neurol 1991 Aug; 48 (8): 822-7
26. Freed CR. Breeze RE, Rosenberg NL, et al. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 1992 Nov; 327 (22): 1549-55
27. Hoffer BJ, Leenders KL, Young D, et al. Eighteen-month course of two patients with grafts of fetal dopamine neurons for severe Parkinson's disease. Exp Neurol 1992 Dec; 118 (3): 243-52
28. Iacono RP, Tang ZS, Mazziotta JC, et al. Bilateral fetal grafts for Parkinson's disease: 22 Months' results. Stereotact Funct Neurosurg 1992; 58 (1-4): 84-7
29. Lindvall O, Widner H, Rehncrona S, et al. Transplantation of fetal dopamine neurons in Parkinson's disease: One-year clinical and neurophysiological observations in two patients with putaminal implants. Ann Neurol 1992 Feb; 31 (2): 155-65
30. Sawle GV, Bloomfield PM, Bjorklund A, et al. Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants. Ann Neurol 1992 Feb; 31 (2): 166-73
31. Widner H, Tetrud J, Rehncrona S, et al. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N Engl J Med 1992 Nov; 327 (22): 1556-63
32. Molina H, Quinones-Molina R, Munoz J, et al. Neurotransplantation in Parkinson's disease: From open microsurgery to bilateral stereotactic approach: First clinical trial using microelectrode recording technique. Stereotact Funct Neurosurg 1994; 62 (1-4): 204-8
33. Peschanski M, Defer G, N'Guyen JP, et al. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 1994 Jun; 117 (3): 487-99
34. Zabek M, Mazurowski W, Dymecki J, et al. A long term follow-up of fetal dopaminergic neurons transplantation into the brain of three parkinsonian patients. Rest Neurol Neurosci 1994; 6: 97-106
35. Freeman TB, Olanow CW, Hauser RA, et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 1995 Sep; 38 (3): 379-88
36. Kordower JH, Freeman TB, Snow BJ, et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 1995 Apt 27; 332 (17): 1118-24
37. Kordower JH, Rosenstein JM, Collier TJ, et al. Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies. J Comp Neurol 1996 Jun; 370 (2): 203-30
38. Madrazo I, Franco-Bourland RE. Castrejon H, et al. Fetal striatal homotransplantation for Huntington's disease: First two case reports. Neurol Res 1995 Aug; 17 (4): 312-5
39. Remy P, Samson Y, Hantraye P, et al. Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients. Ann Neurol 1995 Oct; 38 (4): 580-8
40. Chung CK, Kim HJ, Jeon BS, et al. Unilateral fetal mesencephalic grafting in two patients with Parkinson's disease: Short-term result after transplantation. No Shinkei Geka 1996 Nov; 24 (11): 987-93
41. Defer GL, Geny C, Ricolfi F, et al. Long-term outcome of unilaterally transplanted parkinsonian patients. I: Clinical approach. Brain 1996 Feb; 119 (1): 41-50
42. Kopyov OV, Jacques D, Lieberman A, et al. Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease. Cell Transplant 1996; 5 (2): 327-37
43. Folkerth RD, Durso R. Survival and proliferation of nonneural tissues, with obstruction of cerebral ventricles, in a parkinsonian patient treated with fetal allografts. Neurology 1996 May; 46 (5): 1219-25
44. Kopyov OV, Jacques DS, Lieberman A, et al. Outcome following intrastriatal fetal mesencephalic grafts for Parkinson's patients is directly related to the volume of grafted tissue. Exp Neurol 1997 Aug; 146 (2): 536-45
45. Levivier M, Dethy S, Rodesch F, et al. Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease: Methodology and 6-month to 1-year follow-up in 3 patients. Stereotact Funct Neurosurg 1997; 69 (1-4 Pt 2): 99-111
46. Lopez-Lozano JJ, Bravo G, Brera B, et al. Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-Year follow up in 10 patients. J Neurosurg 1997 Jun; 86 (6): 931-42
47. Philpott LM, Kopyov OV, Lee AJ, et al. Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: Three case presentations. Cell Transplant 1997; 6: 203-11
48. Kopyov OV, Jacques S, Liebermann A, et al. Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp Neurol 1998; 149: 97-108
49. Bluml S, Kopyov O, Jacques S, et al. Activation of neurotransplants in humans. Exp Neurol 1999 Jul; 158 (1): 121-5
50. Hauser RA, Freeman TB, Snow BJ, et al. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch Neurol 1999 Feb; 56 (2): 179-87
51. Jacques DB, Kopyov OV, Eagle KS, et al. Outcomes and complications of fetal tissue transplantation in Parkinson's disease. Stereotact Funct Neurosurg 1999; 72 (2-4): 219-24
52. Piccini P, Brooks DJ, Bjorklund A, et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 1999 Dec; 2 (12): 1137-40
53. Bachoud-Levi AC, Bourdet C, Brugieres P, et al. Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Exp Neurol 2000; 161: 194-202
54. Freeman TB, Cicchetti F, Hauser RA, et al. Transplanted fetal striatum in Huntington's disease: Phenotypic development and lack of pathology. Proc Natl Acad Sci U S A 2000; 97 (25): 13877-82
55. Piccini P, Lindvall O, Bjorklund A, et al. Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol 2000 Nov; 48 (5): 689-95
56. Ugryumov MV. The differentiation of dopaminergic neurons in situ, in vivo, and in transplants. Neurosci Behav Physiol 2000; 30 (1): 37-43
57. Mendez I, Dagher A, Hong M, et al. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: A pilot study. Report of three cases. J Neurosurg 2002 Mar; 96 (3): 589-96
58. Hagell P, Piccini P, Bjorklund A, et al. Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci 2002 Jul; 5 (7): 627-8
59. Palfi S, Nguyen JP, Brugieres P, et al. MRI-stereotactical approach for neural grafting in basal ganglia disorders. Exp Neurol 1998; 150: 272-81
60. Bachoud-Levi AC, Remy P, Nguyen JP, et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 2000; 356 (9246): 1945-6
61. Svendsen CN, Smith AG. New prospects for human stem-cell therapy in the nervous system. Trends Neurosci 1999 Aug; 22 (8): 357-64
62. Thompson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cells lines derived from human blastocysts. Science 1998; 282: 1145-7
63. Reubinoff BE, Itsykson P, et al. Neural progenitors from human embryonic stem cells. Nat Biotechnol 2001 Dec; 19 (12): 1134-40
64. Amit M, Carpenter MK, Inokuma MS, et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 2000; 227: 271-8
65. Vescovi AL, Parati EA, Gritti A, et al. Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation. Exp Neurol 1999 Mar; 156 (1): 71-83
66. Svendsen CN, ter Borg MG, Armstrong RJE, et al. A new method for the rapid and long-term growth of human neural precursor cells. J Neurosci Meth 1998; 85: 141-53
67. Carpenter MK, Cui X, Hu ZY, et al. In vitro expansion of a multipotent population of human neural progenitor cells. Exp Neurol 1999 Aug; 158 (2): 265-78
68. Fricker RA, Carpenter MK, Winkler C, et al. Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J Neurosci 1999 Jul 15; 19 (14): 5990-6005
69. Shihabuddin LS, Horner PJ, Ray J, et al. Adult spinal cord stem cells generate neurons after transplantation in the adult dentate gyrus. J Neurosci 2000 Dec 1; 20 (23): 8727-35
70. Suhonen JO, Peterson DA, Ray J, et al. Differentiation of adult hippocampus-derived progenitors into olfactory neurons in vivo. Nature 1996 Oct 17; 383 (6601): 624-7
71. Cao QL, Zhang YP, Howard RM, et al. Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Exp Neurol 2001 Jan; 167 (1): 48-58
72. Lundberg C, Martinez-Serrano A, Cattaneo E, et al. Survival, integration, and differentiation of neural stem cell lines after transplantation to the adult rat striatum. Exp Neurol 1997 Jun; 145 (2 Pt 1): 342-60
73. Winkler C, Fricker RA, Gates MA, et al. Incorporation and glial differentiation of mouse EGF-responsive neural progenitor cells after transplantation into the embryonic rat brain. Mol Cell Neurosci 1998 Jun; 11 (3): 99-116
74. Snyder EY, Yoon C, Flax JD, et al. Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex. Proc Natl Acad Sci U S A 1997 Oct 14; 94 (21): 11663-8
75. Zhang SC, Wernig M, Duncan ID, et al. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 2001 Dec; 19 (12): 1129-33
76. Herrera DG, Garcia-Verdugo JM, Alvarez-Buylla A. Adult-derived neural precursors transplanted into multiple regions in the adult brain. Ann Neurol 1999 Dec; 46 (6): 867-77
77. Shin JJ, Fricker-Gates RA, Perez FA, et al. Transplanted neuroblasts differentiate appropriately into projection neurons with correct neurotransmitter and receptor phenotype in neocortex undergoing targeted projection neuron degeneration. J Neurosci 2000 Oct 1; 20 (19): 7404-16
78. Wang Y, Sheen VL, Macklis JD. Cortical interneurons upregulate neurotrophins in vivo in response to targeted apoptotic degeneration of neighboring pyramidal neurons. Exp Neurol 1998 Dec; 154 (2): 389-402
79. Qu T, Brannen CL, Kim M, et al. Human neural stem cells improve cognitive function of aged brain. Neuroreport 2001; 12: 1127-32
80. Tamaki S, Eckert K, He D, et al. Engraftment of sorted/expanded human central nervous system stem cells from fetal brain. J Neurosci Res 2002 Sep; 69 (6): 976-86
81. Svendsen CN, Clarke DJ, Rosser AE, et al. Survival and differentiation of rat and human epidermal growth factor-responsive precursor cells following grafting into the lesioned adult central nervous system. Exp Neurol 1996 Feb; 137 (2): 376-88
82. Svendsen CN, Caldwell MA, Shen J, et al. Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease. Exp Neurol 1997 Nov; 148 (1): 135-46
83. Ostenfeld T, Caldwell MA, Prowse KR, et al. Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation. Exp Neurol 2000 Jul; 164 (1): 215-26
84. Sheen VL, Arnold MW, Wang Y, et al. Neural precursor differentiation following transplantation into neocortex is dependent on intrinsic developmental state and receptor competence. Exp Neurol 1999 Jul; 158 (1): 47-62
85. Caldwell MA, He X, Wilkie N, et al. Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat Biotechnol 2001 May; 19 (5): 475-9
86. Ahmed S, Reynolds BA, Weiss S. BDNF enhances the differentiation but not the survival of CNS stem cell-derived neuronal precursors. J Neurosci 1995 Aug; 15 (8): 5765-78
87. Deacon T, Dinsmore J, Costantini LC, et al. Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation. Exp Neurol 1998 Jan; 149 (1): 28-41
88. Bjorklund LM, Sanchez-Pernaute R, Chung S, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A 2002 Feb 19; 99 (4): 2344-9
89. Yan J, Studer L, McKay R. Ascorbic acid increases the yield of dopaminergic neurons derived from basic fibroblast growth factor expanded mesencephalic precursors. J Neurochem 2001; 76: 307-11
90. Storch A, Paul G, Csete M, et al. Long-term proliferation and dopaminergic differentiation of human mesencephalic neural precursor cells. Exp Neurol 2001 Aug; 170 (2): 317-25
91. Biesecker LG, Emerson SG. Interleukin-6 is a component of human umbilical cord serum and stimulates hematopoiesis in embryonic stem cells in vitro. Exp Hematol 1993 Jun; 21 (6): 774-8
92. Bain G, Kitchens D, Yao M, et al. Embryonic stem cells express neuronal properties in vitro. Dev Biol 1995 Apr; 168 (2): 342-57
93. Rohwedel J, Guan K, Wobus AM. Induction of cellular differentiation by retinoic acid in vitro. Cells Tissues Organs 1999; 165 (3-4): 190-202
94. Toresson H, Mata de Urquiza A, Fagerstrom C, et al. Retinoids are produced by glia in the lateral ganglionic eminence and regulate striatal neuron differentiation. Development 1999 Mar; 126 (6): 1317-26
95. Schuldiner M, Yanuka O, Itskovitz-Eldor J, et al. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 2000 Oct 10; 97 (21): 11307-12
96. Schuldiner M, Eiges R, Eden A, et al. Induced neuronal differentiation of human embryonic stem cells. Brain Res 2001 Sep 21; 913 (2): 201-5
97. Pleasure SJ and Lee VM. NTera 2 cells: A human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J Neurosci Res 1993 Aug 15; 35 (6): 585-602
98. Levinson-Dushnik M, Benvenisty N. Involvement of hepatocyte nuclear factor 3 in endoderm differentiation of embryonic stem cells. Mol Cell Biol 1997 Jul; 17 (7): 3817-22
99. Li M, Pevney L, Lovell-Badge R, et al. Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr Biol 1998; 8 (17): 971-4
100. Nieto M, Schuurmans C, Britz O, et al. Neural bHLH genes control the neuronal versus glial fate decision in cortical progenitors. Neuron 2001 Feb; 29 (2): 401-13
101. Sun Y, Nadal-Vicens M, Misono S, et al. Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. Cell 2001 Feb 9; 104 (3): 365-76
102. Smith AG. Embryo-derived stem cells: Of mice and men. Annu Rev Cell Dev Biol 2001; 17: 435-62
103. Morrison SJ. Neuronal potential and lineage determination by neural stem cells. Curr Opin Cell Biol 2001 Dec; 13 (6): 666-72
104. Song H, Stevens CF, Gage FH. Astroglia induce neurogenesis from adult neural stem cells. Nature 2002 May; 417: 39-44
105. Studer L, Csete M, Lee SH, et al. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci 2000; 20: 7377-83
106. Potter ED, Ling ZD, Carvey PM. Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons. Cell Tissue Res 1999 May; 296 (2): 235-46
107. Carvey PM, Ling ZD, Sortwell CE, et al. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: A source of cells for transplantation in Parkinson's disease. Exp Neurol 2001 Sep; 171 (1): 98-108
108. Sanchez-Pernaute R, Studer L, Bankiewicz KS, et al. In vitro generation and transplantation of precursor-derived human dopamine neurons. J Neurosci Res 2001 Aug 15; 65 (4): 284-8
109. Lee S, Lumelsky N, Studer L, et al. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nature 2000 Jun; 18: 675-9
110. Stull ND, Iacovitti L. Sonic hedgehog and FGF8: Inadequate signals for the differentiation of a dopamine phenotype in mouse and human neurons in culture. Exp Neurol 2001 May; 169 (1): 36-43
111. Wagner J, Akerud P, Castro DS, et al. Induction of a midbrain dopaminergic phenotype in Nurrl-overexpressing neural stem cells by type 1 astrocytes. Nat Biotechnol 1999; 17 (7): 653-9
112. Daadi MM, Weiss S. Generation of tyrosine hydroxylase-producing neurons from precursors of the embryonic and adult forebrain. J Neurosci 1999 Jun 1; 19 (11): 4484-97
113. Panchision DM, Martin-DeLeon PA, Takeshima T, et al. An immortalized, type-1 astrocyte of mesencephalic origin source of a dopaminergic neurotrophic factor. J Mol Neurosci 1998 Dec; 11 (3): 209-21
114. Takeshima T, Shimoda K, Sauve Y, et al. Astrocyte-dependent and -independent phases of the development and survival of rat embryonic day 14 mesencephalic, dopaminergic neurons in culture. Neuroscience 1994 Jun; 60 (3): 809-23
115. Takeshima T, Johnston JM, Commissiong JW. Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation. J Neurosci 1994 Aug; 14 (8): 4769-79
116. Layton ME, Pazdernik TL, Samson FE. Cerebral penetration injury leads to H2O2 generation in microdialysis samples. Neurosci Lett 1997; 236 (2): 63-6
117. Layton ME, Wagner JK, Samson FE, et al. Redox changes in perfusates following intracerebral penetration of microdialysis probes. Neurochem Res 1997; 22 (6): 735-41
118. Yergey JA and Heyes MP. Brain eicosanoid formation following acute penetration injury as studied by in vivo microdialysis. J Cereb Blood Flow Metab 1990; 10 (1): 143-6
119. Othberg A, Keep M, Brundin P, et al. Tirilazad mesylate improves survival of rat and human embryonic mesencephalic neurons in vitro. Exp Neurol 1997 Oct; 147 (2): 498-502
120. Grasbon-Frodl EM, Nakao N, Brundin P. The lazaroid U-83836E improves the survival of rat embryonic mesencephalic tissue stored at 4 degrees C and subsequently used for cultures or intracerebral transplantation. Brain Res Bull 1996; 39 (6): 341-7
121. Hansson O, Castilho RF, Kaminski Schierle GS, et al. Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human embryonic dopamine neurons. Exp Neurol 2000 Jul; 164 (1): 102-11
122. Bjorklund L, Spenger C, Stromberg I. Tirilazad mesylate increases dopaminergic neuronal survival in the in Oculo grafting model. Exp Neurol 1997 Nov; 148 (1): 324-33
123. Karlsson J, Love RM, Clarke DJ, et al. Effects of anaesthetics and lazaroid U-83836E on survival of transplanted rat dopaminergic neurones. Brain Res 1999 Mar 13; 821 (2): 546-50
124. Ouyang YB, He QP, Li PA, et al. Is neuronal injury caused by hypoglycaemic coma of the necrotic or apoptotic type? Neurochem Res 2000 May; 25 (5): 661-7
125. Cavaliere F, D'Ambrosi N, Sancesario G, et al. Hypoglycemia-induced cell death: Features of neuroprotection by the P2 receptor antagonist basilen blue. Neurochem Int 2001 Mar; 38 (3): 199-207
126. Gwag BJ, Lobner D, Koh JY, et al. Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro. Neuroscience 1995 Oct; 68 (3): 615-9
127. Freed WJ. Transplantion of tissues to the cerebral ventricles: Methodological details and rate of graft survival. In: Bjorklund A, Stenevi U, editors. Neural Grafting in the Mammalian CNS. Amsterdam: Elsevier, 1985; 32-40
128. Rosenstein JM, Brightman MW. Intact cerebral ventricle as a site for tissue transplantation. Nature 1978 Nov 2; 276 (5683): 83-5
129. Nikkhah G, Cunningham MG, Jodicke A, et al. Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res 1994 Jan 7; 633 (1-2): 133-43
130. Leigh K, Elisevich K, Rogers KA. Vascularization and microvascular permeability in solid versus cell-suspension embryonic neural grafts. J Neurosurg 1994 Aug; 81 (2): 272-83
131. Le Belle JE, Caldwell MA, Svendsen CN. Improving the survival of human CNS precursor-derived cells following transplantation [abstract 371.8]. Proceeding of the Society for Neuroscience; Nov 2001, San Diego, USA (manuscript in preparation)
132. Clarkson ED, Zawada WM, Freed CR. GDNF improves survival and reduces apoptosis in human embryonic dopaminergic neurons in vitro. Cell Tissue Res 1997 Aug; 289 (2): 207-10
133. Clarkson ED, Zawada WM, Bell KP, et al. [GF-I and bFGF improve dopamine neuron survival and behavioral outcome in parkinsonian rats receiving cultured human fetal tissue strands. Exp Neurol 2001 Mar; 168 (1): 183-91
134. Knusel B, Michel PP, Schwaber JS, et al. Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II. J Neurosci 1990 Feb; 10 (2): 558-70
135. Takayama H, Ray J, Raymon HK, et al. Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nat Med 1995 Jan; 1 (1): 53-8
136. Akerud P, Canals JM, Snyder EY, et al. Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease. J Neurosci 2001 Oct 15; 21 (20): 8108-18
137. Schierle GS, Leist M, Martinou JC, et al. Differential effects of Bcl-2 overexpression on fibre outgrowth and survival of embryonic dopaminergic neurons in intracerebral transplants. Eur J Neurosci 1999 Sep; 11 (9): 3073-81
138. Engele J, Bohn MC. The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J Neurosci 1991 Oct; 11 (10): 3070-8
139. Sinson G, Voddi M, McIntosh TK. Combined fetal neural transplantation and nerve growth factor infusion: Effects on neurological outcome following fluid-percussion brain injury in the rat. J Neurosurg 1996 Apr; 84 (4): 655-62
140. Emerich DF. Encapsulated CNTF-producing cells for Huntington's disease. Cell Transplant 1999; 8 (6): 581-2
141. Shingo T, Date I, Yoshida H, et al. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease. J Neurosci Res 2002 Sep; 69 (6): 946-54
142. Ostenfeld T, Tai YT, Martin P, et al. Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons. J Neurosci Res 2002 Sep; 69 (6): 955-65
143. Mahoney MJ, Saltzman WM. Transplantation of brain cells assembled around a programmable synthetic microenvironment. Nat Biotechnol 2001 Oct; 19 (10): 934-9
144. Dobrossy MD, Dunnett SB. The influence of environment and experience on neural grafts. Nat Rev Neurosci 2001 Dec; 2 (12): 871-9
145. Bjornson CR, Rietze RL, Reynolds BA, et al. Turning brain into blood: A hematopoietic fate adopted by adult neural stem cells in vivo. Science 1999 Jan 22; 283 (5401): 534-7
146. Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 1999 Sep 14; 96 (19): 10711-6
147. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000 Nov; 6 (11): 1229-34
148. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001 Apr 5; 410 (6829): 701-5
149. Woodbury D, Schwarz EJ, Prockop DJ, et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000 Aug 15; 61 (4): 364-70
150. Romero-Ramos M, Vourch P, Young HE, et al. Neuronal differentiation of stem cells isolated from adult muscle. J Neurosci Res 2002 Sep; 69 (6): 894-907
151. Lowenstein PR. Immunology of viral-vector-mediated gene transfer into the brain: An evolutionary and developmental perspective. Trends Immunol 2002 Jan; 23 (1): 23-30
152. Brevig T, Pedersen EB, Finsen B. Molecular and cellular mechanisms in immune rejection of intracerebral neural transplants. Novartis Found Symp 2000; 231: 166-77
153. Svendsen CN, Bhattacharyya A, Tai YT. Neurons from stem cells: Preventing an identity crisis. Nat Rev Neurosci 2001 Nov; 2 (11): 831-4
154. Clarke DL, Johansson CB, Wilbertz J, et al. Generalized potential of adult neural stem cells. Science 2000 Jun 2; 288 (5471): 1660-3
155. Morshead CM, Benveniste P, Iscove NN, et al. Hematopoietic competence is a rare property of neural stem cells that may depend on genetic and epigenetic alterations. Nat Med 2002 Mar; 8 (3): 268-73
156. Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002 Apr 4; 416 (6880): 542-5
157. Ying Q, Nichols J, Evans EP, et al. Changing potency by spontaneous fusion. Nature 2002 Apt 4; 416 (6880): 545-8
158. Morrison SJ. Stem cell potential: Can anything make anything? Curr Biol 2001 Jan 9; 11 (1): R7-9
159. Anderson DJ, Gage FH, Weissman IL. Can stem cells cross lineage boundaries? Nat Med 2001 Apr; 7 (4): 393-5
160. Gould E, Vail N, Wagers M, et al. Adult-generated hippocampal and neocortical neurons in macaques have a transient existence. Proc Natl Acad Sci U S A 2001 Sep 11; 98 (19): 10910-7
161. Kempermann G, Kuhn HG, Gage FH. More hippocampal neurons in adult mice living in an enriched environment. Nature 1997 Apr 3; 386 (6624): 493-5
162. Lois C, Alvarez-Buylla A. Long-distance neuronal migration in the adult mammalian brain. Science 1994 May 20; 264 (5162): 1145-8
163. Kornack DR, Rakic P. The generation, migration, and differentiation of olfactory neurons in the adult primate brain. Proc Natl Acad Sci U S A 2001 Apr 10; 98 (8): 4752-7
164. Magavi SS, Leavitt BR, Macklis JD. Induction of neurogenesis in the neocortex of adult mice. Nature 2000 Jun 22; 405 (6789): 951-5
165. Biebl M, Cooper CM, Winkler J, et al. Analysis of neurogenesis and programmed cell death reveals a self-renewing capacity in the adult rat brain. Neurosci Lett 2000 Sep 8; 291 (1): 17-20
166. Liu J, Solway K, Messing RO, et al. Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J Neurosci 1998 Oct 1; 18 (19): 7768-78
167. Kuhn HG, Svendsen CN. Origins, functions, and potential of adult neural stem cells. Bioessays 1999 Aug; 21 (8): 625-30
168. Kuhn HG, Palmer TD, Fuchs E. Adult neurogenesis: A compensatory mechanism for neuronal damage. Eur Arch Psychiatry Clin Neurosci 2001 Aug; 251 (4): 152-8
169. Gould E and Gross CG. Neurogenesis in adult mammals: Some progress and problems. J Neurosci 2002 Feb 1; 22 (3): 619-23
170. Kempermann G. Why new neurons? possible functions for adult hippocampal neurogenesis. J Neurosci 2002 Feb 1; 22 (3): 635-8
171. Rakic P. Neurogenesis in adult primate neocortex: An evaluation of the evidence. Nat Rev Neurosci 2002 Jan; 3 (1): 65-71
172. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992 Mar; 255 (5052): 1707-10
173. Brewer GJ. Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J Neurosci Res 1995 Dec; 42 (5): 674-83
174. Colombo JA, Napp M, Medana A. Regional differences in in vitro growth of neural cell processes during development. Int J Dev Neurosci 1996 Jul; 14 (4): 497-505
175. Ostenfeld T, Joly E, Tai YT, et al. Regional specification of rodent and human neurospheres. Brain Res Dev Brain Res 2002 Mar; 134 (1-2): 43-55
176. Arvidsson A, Collin T, Kirik D, et al. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 2002 Aug; 8
177. Benraiss A, Chmielnicki E, Lerner K, et al. Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain. J Neurosci 2001 Sep; 21 (17): 6718-31
178. Zhang RL, Zhang ZG, Zhang L, et al. Proliferation and differentiation of progenitor cells in the cortex and the subventricular zone in the adult rat after focal cerebral ischemia. Neuroscience 2001; 105 (1): 33-41
179. Jin K, Minami M, Lan JQ, et al. Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc Natl Acad Sci U S A 2001 Apr; 98 (8): 4710-5
180. Bengzon J, Kokaia Z, Elmer E, et al. Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc Natl Acad Sci U S A 1997 Sep; 94 (19): 10432-7
181. Parent JM, Yu TW, Leibowitz RT, et al. Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J Neurosci 1997 May; 17 (10): 3727-38
182. Arvidsson A, Kokaia Z, & Lindvall O. N-methyl-D-aspartate receptor-mediated increase of neurogenesis in adult rat dentate gyrus following stroke. Eur J Neurosci 2001 Jul; 14 (1): 10-8
183. Decker L, Picard-Riera N, Lachapelle F, et al. Growth factor treatment promotes mobilization of young but not aged adult subventricular zone precursors in response to demyelination. J Neurosci Res 2002 Sep; 69 (6): 763-71
184. Jin K, Mao XO, Sun Y, et al. Stem cell factor stimulates neurogenesis in vitro and in vivo. J Clin Invest 2002 Aug; 110 (3): 311-9
185. Jin K, Zhu Y, Sun Y, et al. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci U S A 2002 Sep 3; 99 (18): 11946-50
186. Monje ML, Mizumatsu S, Fike JR, et al. Irradiation induces neural precursor-cell dysfunction. Nat Med 2002 Sep; 8 (9): 955-62